Compare VICR & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VICR | TMDX |
|---|---|---|
| Founded | 1981 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 3.4B |
| IPO Year | 1995 | 2019 |
| Metric | VICR | TMDX |
|---|---|---|
| Price | $159.94 | $99.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $132.50 | ★ $154.00 |
| AVG Volume (30 Days) | 767.8K | ★ 934.9K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1764.29 | 382.18 |
| EPS | 2.61 | ★ 4.87 |
| Revenue | $452,701,000.00 | ★ $605,494,000.00 |
| Revenue This Year | $37.01 | $24.51 |
| Revenue Next Year | $39.47 | $18.73 |
| P/E Ratio | $54.71 | ★ $19.34 |
| Revenue Growth | 26.08 | ★ 37.13 |
| 52 Week Low | $38.93 | $62.42 |
| 52 Week High | $209.53 | $156.00 |
| Indicator | VICR | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 45.87 | 29.56 |
| Support Level | $158.17 | N/A |
| Resistance Level | $177.00 | $131.86 |
| Average True Range (ATR) | 15.10 | 5.79 |
| MACD | -4.37 | -2.31 |
| Stochastic Oscillator | 35.30 | 17.21 |
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others. The principal markets for the Company's power converters and systems are large original equipment manufacturers (OEMs), original design manufacturers (ODMs) and their contract manufacturers, and smaller, lower volume users, which are broadly distributed across several market areas.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.